GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Research & Development

GNTA (Genenta Science SPA) Research & Development : $5.10 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genenta Science SPA's Research & Development for the six months ended in Dec. 2024 was $2.90 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $5.10 Mil.

Genenta Science SPA Research & Development Historical Data

The historical data trend for Genenta Science SPA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Research & Development Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 5.70 3.83 5.66 7.06 5.04

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.92 4.25 2.78 2.20 2.90

Genenta Science SPA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genenta Science SPA  (NAS:GNTA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genenta Science SPA Research & Development Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Research & Development
Comparable Companies
STU:T9G XTER:MDG1 XTER:HPHA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB
Traded in Other Exchanges
N/A
Address
Via Olgettina No. 58, Milan, ITA, 20132
Website
https://www.genenta.com
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.